drugset / Trial / NCT00422188

Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

NCT00422188

Phase 1 Completed 16 enrolled Kythera Biopharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research is to compare the safety and effectiveness of 4 different concentrations of deoxycholic acid injection against a placebo in the treatment of superficial lipomas.

Timeline

Start
2007-01
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule 0.5 % Other
Subject Deoxycholic Acid Small molecule 1 % Other
Subject Deoxycholic Acid Small molecule 2 % Other
Subject Deoxycholic Acid Small molecule 4 % Other

Indications